Zu "603288-22-8" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
LY2090314
Artikelnummer: TGM-T1755-100mg
Description: LY2090314, an effective GSK-3alpha/beta inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer. Target: GSK-3. Smiles:...
| Anwendung: | GSK-3alpha / GSK-3beta inhibitor |
| CAS | 603288-22-8 |
| MW: | 512.53 D |
ab 42,00 €
LY2090314
Artikelnummer: Cay22211-1
LY2090314 is potent and selective inhibitor of glycogen synthase kinase 3 (GSK3) with IC50 values of 1.5 and 0.9 nM for human recombinant GSK3alpha and GSK3beta, respectively. It has >10-fold selectivity for GSK3 over a panel of 40 kinases at a concentration of 20 µM. LY2090314 induces time-dependent stabilization...
| Schlagworte: | 3-[9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepin-7-yl]-4-imidazo[1,2-a]pyridin-... |
| Anwendung: | GSK-3alpha / GSK-3beta inhibitor |
| CAS | 603288-22-8 |
| MW: | 512.5 D |
ab 44,00 €
LY-2090314
Artikelnummer: LKT-L9600.1
LY2090314 is an inhibitor of glycogen synthase kinase (GSK-3).
| Anwendung: | GSK-3 inhibitor |
| CAS | 603288-22-8 |
| MW: | 512.53 D |
ab 236,00 €
